4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-10-09NCT06757634
DurAVR™ THV EU-EFSAortic Valve, Calcification of, Ventricular Outflow Obstruction, aortic valve calcification, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorderActive, not recruitingNot applicable2026-09-16NCT06510855
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV SystemAortic Valve, Calcification of, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorderRecruitingNot applicable2026-07-15NCT07194265
Long-term Safety and Performance of Materialise's Patient-specific TMJ System.Craniomandibular Disorders, Jaw Diseases, Mandibular Diseases, Stomatognathic Diseases, arthropathy, muscle tissue disorder, musculoskeletal system disorder, temporomandibular joint disorderNot yet recruitingNot stated2025-04-30NCT06951178